1. Home
  2. CCO vs ORIC Comparison

CCO vs ORIC Comparison

Compare CCO & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.40

Market Cap

1.2B

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

BUY

Current Price

$12.33

Market Cap

1.4B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
CCO
ORIC
Founded
1995
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
CCO
ORIC
Price
$2.40
$12.33
Analyst Decision
Hold
Strong Buy
Analyst Count
3
16
Target Price
$2.43
★ $21.43
AVG Volume (30 Days)
★ 4.2M
1.3M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
★ 23.24%
N/A
EPS Growth
★ 110.81
19.67
EPS
★ N/A
N/A
Revenue
★ $1,604,140,000.00
N/A
Revenue This Year
$7.33
N/A
Revenue Next Year
$2.33
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 6.57
N/A
52 Week Low
$1.27
$7.23
52 Week High
$2.44
$14.68

Technical Indicators

Market Signals
Indicator
CCO
ORIC
Relative Strength Index (RSI) 56.08 42.29
Support Level $2.37 $11.86
Resistance Level $2.41 $12.59
Average True Range (ATR) 0.02 0.73
MACD 0.00 -0.05
Stochastic Oscillator 81.25 20.38

Price Performance

Historical Comparison
CCO
ORIC

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: